about
Mitochondrially localised MUL1 is a novel modulator of antiviral signalingUbiquitin in the activation and attenuation of innate antiviral immunityBrinp1(-/-) mice exhibit autism-like behaviour, altered memory, hyperactivity and increased parvalbumin-positive cortical interneuron densityEpitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complexStructure of the haemagglutinin-neuraminidase from human parainfluenza virus type IIIA T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I moleculeCD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptorA structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac diseaseThe Structure of the Bacterial Oxidoreductase Enzyme DsbA in Complex with a Peptide Reveals a Basis for Substrate Specificity in the Catalytic Cycle of DsbA EnzymesA small molecule glycosaminoglycan mimetic blocks Plasmodium invasion of the mosquito midgutThe Anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitopeA structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.Smoothing a rugged protein folding landscape by sequence-based redesign.Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.The production and crystallization of the human leukocyte antigen class II molecules HLA-DQ2 and HLA-DQ8 complexed with deamidated gliadin peptides implicated in coeliac disease.CTL recognition of a bulged viral peptide involves biased TCR selection.The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance.Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V.Understanding the structural dynamics of TCR-pMHC complex interactions.Proteomic Identification of Interferon-Induced Proteins with Tetratricopeptide Repeats as Markers of M1 Macrophage Polarization.Previously Hidden Dynamics at the TCR-Peptide-MHC Interface Revealed.Germline-encoded recognition of diverse glycolipids by natural killer T cellsThe CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognitionThe Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity SyndromePreviously Hidden Dynamics at the TCR-pMHC Interface RevealedStructural Capacitance in Protein Evolution and Human DiseasesRIG-I like receptorsStructural Capacitance in Protein Evolution and Human DiseasesExportin-1-Dependent Nuclear Export of DEAD-box Helicase DDX3X is Central to its Role in Antiviral ImmunityThe Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity SyndromeRK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X
P50
Q24316185-049D22CD-3FB5-46A5-9022-C9D06F5EA71AQ26771789-F8DF8077-E471-4BB3-9D3D-BA7E6DB46650Q27322895-28BFDF37-8164-45B2-8931-E6452D15E168Q27331858-77BD15DE-95C2-465C-82DB-492B3FFC32BFQ27642969-C5AA7A15-8FA8-492A-945E-7E9DDC639839Q27643687-BF89834A-DDC6-478E-9534-871C43EAF308Q27646101-683D4AE4-3D33-4506-A786-1735FE144FE8Q27646673-76877C2E-4FEE-413A-B9AF-7DD6EC6733B6Q27655136-3640F988-9149-4DBC-8419-8883C46C3B5AQ28535338-BBEB7E18-DA1F-4432-A127-06AA337B6584Q35989209-5218E0CE-700C-43DA-ADE9-A95F4B3ABD47Q36228473-EC523580-B303-403B-8786-BBD666C58141Q36403686-DD0AAF87-D6E6-4CBE-9B3C-4DF8B7BDDDFAQ36537962-4EBFC665-916B-4996-AD62-E56B1C320FBBQ37282499-8762FDE9-2EF8-4C35-9504-052563AB9153Q37546481-9C651890-A85E-4CA3-833F-BF0F70D60CF2Q40212583-75360CA7-B9F2-4A6C-A1C3-6ACB5E1E4839Q40368484-46F642E0-0445-45F3-804A-BF556744512EQ40431345-186F44E9-DE26-4F56-AE8C-3CE4995CBD1FQ41931902-6E2561D1-27C0-470A-B0DA-198AFDA1CE50Q43532894-AC740735-9299-4078-9869-0DF063A1833EQ45624427-543DE45D-9EFA-410F-9F51-397C789739ABQ47555704-A768AF09-85D6-41A5-A1C2-9399DB8E19C9Q51028736-3D653B1D-69B7-4685-A836-E243C1CBEB01Q52672417-E2EE9609-C610-4F0A-8C1F-BC0E8882ACC3Q54220723-2B2F2EB1-FB4A-4BD0-A146-41AE5BE78B45Q56917232-FECD40BC-08E6-490A-91BA-E04FEEB7CBAFQ56917578-25A03090-0BEC-4473-8B7B-A2830015DDBAQ58022590-435E7115-6A80-4068-B3EA-11557A8576FCQ58022592-951493AA-9DD6-43CE-9C41-C5EBB7807E77Q60456582-EA48E4B8-7586-4AB7-A236-3BD9EDDD414FQ62604415-D8ECF43E-BDE4-4CB7-A1FE-A199BB1D93B9Q63362232-D906377C-9F77-4CE4-8C43-F03A2DB6146CQ90419955-EB40B209-0E69-41FE-BA7D-7C0E651464D5Q92035357-9CF7C5E8-B67D-4606-B226-452BD2908529Q92636216-A3C8AFFA-7DE0-4EF2-BA9A-F7AC863007FF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Natalie A Borg
@ast
Natalie A Borg
@en
Natalie A Borg
@es
Natalie A Borg
@nl
Natalie A Borg
@sl
type
label
Natalie A Borg
@ast
Natalie A Borg
@en
Natalie A Borg
@es
Natalie A Borg
@nl
Natalie A Borg
@sl
prefLabel
Natalie A Borg
@ast
Natalie A Borg
@en
Natalie A Borg
@es
Natalie A Borg
@nl
Natalie A Borg
@sl
P106
P21
P31
P496
0000-0002-8677-9056